7FDA. Guidance for industry: Evaluating clinical studies of antimicrobials in the division of anti -infective drugs products[ EB/OL]. http:// www. fda. gov/cder/guidance/draft 9 al. pdf, 1997 - 02 - 18.
8Smith C, Burley C, Ireson M, et al. Clinical trials of antibacterial agents : a practical guide to design and analysis [ J ]. J Antimicrob Chemother, 1998; 41 : 467 - 480.
9EMEA. Note for Guidance on evaluation of medicinal products indicated for treatment of bacterial infections [ EB/OL ]. http ://www. emea. euro- pa. eu/pdfs/human/ewp/055895 en. pdf,2004 - 04 - 22.
10[7]S Vergnano,M Sharland,P Kazembe,et al.Neonatal sepsis:an international perspective.Archives of Disease in Childhood Fetal and Neonatal Edition,2005,90:F220-FF224
1Zhou WF, Chen Q, Jin MF. et al. The diagnostic accuracy of high- mobility group box I protein and twelve other markers in discriminating bacterial, viral and co-infected bronchial pneumonia in Han children.[JI.Microbiology and Immunology,2011,55(4):279- 288.
